Canbud Distribution Corporation

Recent News

  • Canbud Appoints Nutraceuticals and Plant Based Wellness Industry Expert

    Toronto, Ontario--(Newsfile Corp. - January 7, 2021) -  Canbud Distribution Corp. (CSE: CBDX) (FSE: CD0) ("Canbud" or the "Company"). The company is pleased to announce the appointment of Adrian Burke to the position of Vice-President, Marketing.Adrian is a serial entrepreneur with multiple exits and brings an immense amount of passion with his studious nature. His twenty-four years of brand development, marketing, and business development experience leverages the dynamic Canbud team. Adrian's previous focus in the nutraceutical space, and his insights...

    2021-01-07 7:07 AM ET
  • Canbud Distribution Develops CBD Patient Distribution Network to Leverage Federal Sales License

    Toronto, Ontario--(Newsfile Corp. - December 29, 2020) - Canbud Distribution Corp. (CSE: CBDX) (FSE: CD0) ("Canbud" or the "Company") is pleased to announce that it has signed an agreement with a cannabis clinic to develop a CBD patient distribution network.Robert Tjandra, COO of Canbud comments, "this initiative demonstrates the Company's continuing execution of the business plan to generate revenue. The CBD revenue stream forms a composite of an overall plan to create multiple revenue streams. The patient distribution network development...

    2020-12-29 7:07 AM ET
  • Canbud Distribution Develops DNA Markers for Mushrooms

    Toronto, Ontario--(Newsfile Corp. - December 17, 2020) - Canbud Distribution Corp. (CSE: CBDX) (FSE: CD0) ("Canbud" or the "Company") is pleased to announce that it has initiated the scientific application of DNA markers for mushroom improvement.Robert Tjandra, COO of Canbud comments, "this initiative demonstrates the Company's continuing application of Science and Technology to achieve a better understanding of the genetics of both functional mushrooms and psychedelic mushrooms. The Company will be able to identify and develop strains with specific substances...

    2020-12-17 7:07 AM ET
  • Canbud Distribution Develops Medicinal Mushroom Immune Support Products

    Toronto, Ontario--(Newsfile Corp. - December 14, 2020) - Canbud Distribution Corp. (CSE: CBDX) (FSE: CD0) ("Canbud" or the "Company") Canbud is pleased to announce that it has started the development of medicinal mushroom immune support products.As per the report published by Fior Markets, the global immune health supplements market is expected to grow from USD 16.32 billion in 2019 to USD 29.40 billion by 2027, at a CAGR of 7.4% during the forecast period 2020-2027.Immunity care has become a critical...

    2020-12-14 7:07 AM ET
  • Canbud Distribution Enters Psychedelics Market To Expand On Health And Wellness Theme

    Toronto, Ontario--(Newsfile Corp. - December 7, 2020) - Canbud Distribution Corp. (CSE: CBDX) (FSE: CD0) ("Canbud" or the "Company"). Canbud has entered into a definitive agreement dated Dec 4, 2020, pursuant to which it will acquire 100 per cent of the issued and outstanding securities of 2688453 Ontario Ltd.Through this opportunistic acquisition, Canbud has secured an approved 2-acre psilocybin production site near Negril, Jamaica with an allowance for expansion up to 20 acres. The acquisition also includes plans to...

    2020-12-07 7:07 AM ET
  • Canbud Distribution Announces Listing on Frankfurt Stock Exchange

    Toronto, Ontario--(Newsfile Corp. - December 3, 2020) - Canbud Distribution Corporation (CSE: CBDX) (FSE: CD0) (the "Corporation") is pleased to announce its common shares have been accepted for listing on the Frankfurt Stock Exchange (FSE) under the trading symbol "CD0". As a result, the company's common shares are now cross-listed on the CSE and the FSE.Raj Ravindran CFO comments, "The Frankfurt listing will help increase trading liquidity and facilitate investment in the Company by institutional and retail investors across...

    2020-12-03 7:07 AM ET
  • Canbud Distribution Announces Granting of Federal Sales Licence for Medical Purposes

    Toronto, Ontario--(Newsfile Corp. - December 1, 2020) -  Canbud Distribution Corporation (CSE: CBDX) (the "Corporation") is pleased to announce that it has been granted a Federal Sales License for Medical Purposes by Health Canada.The global medical cannabis market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 82.19 billion by 2027 growing at a CAGR of 20.25% in the above-mentioned forecast period. Increasing awareness...

    2020-12-01 7:07 AM ET
  • Canbud Distribution Announces Closing of Private Placement for Gross Proceeds of $500,000

    Toronto, Ontario--(Newsfile Corp. - November 24, 2020) -  Canbud Distribution Corporation (CSE: CBDX) (the "Corporation") is pleased to announce the closing of a non-brokered private placement financing (the "Offering") of gross proceeds of $500,000 through the issuance of 5,000,000 units (each, a "Unit") at a price of $0.10 per Unit. Each Unit is comprised of one common share in the capital of the Corporation (each a "Common Share") and one common share purchase warrant (each a "Warrant"). Each Warrant...

    2020-11-24 5:15 PM ET